ReNAgade Therapeutics

Cambridge, United States

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

$300.0M raised

May 2023

Series A

Biotechnology Medical Therapeutics

Top Investors

MPM Capital F2 Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ReNAgade Therapeutics

How much funding has ReNAgade Therapeutics raised?

ReNAgade Therapeutics has raised $300.0M in total funding. The most recent round was Series A. The last funding was announced in May 2023.

Who are ReNAgade Therapeutics's investors?

ReNAgade Therapeutics's investors include MPM Capital, F2 Ventures.

Where is ReNAgade Therapeutics headquartered?

ReNAgade Therapeutics is headquartered in Cambridge, United States.

What does ReNAgade Therapeutics do?

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

What stage is ReNAgade Therapeutics at?

ReNAgade Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 23, 2023.

MLA

"ReNAgade Therapeutics — Funding & Investors." VCBacked, May 23, 2023, https://www.vcbacked.co/company/renagade-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). ReNAgade Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/renagade-therapeutics

Wikipedia (cite web)

{{cite web |title=ReNAgade Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/renagade-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 23, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K